NCT05573230View on ClinicalTrials.gov

A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

January 17, 2023

Study Completion Date

January 17, 2023

Conditions
Healthy
Interventions
DRUG

Midazolam

Administered orally.

DRUG

LY3502970

Administered orally.

DRUG

Cyclosporine

Administered orally.

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY